Straumann Holding AG Net Income/Loss 2012-2024 | SAUHY
Straumann Holding AG annual/quarterly net income/loss history and growth rate from 2012 to 2024. Net income/loss can be defined as the company's total income or loss before preferred stock dividends, taken from the Income Statement
- Straumann Holding AG net income/loss for the quarter ending December 31, 2024 was $0.522B, a 172.27% increase year-over-year.
- Straumann Holding AG net income/loss for the twelve months ending December 31, 2024 was $1.689B, a 235.91% increase year-over-year.
- Straumann Holding AG annual net income/loss for 2024 was $0.522B, a 89.85% increase from 2023.
- Straumann Holding AG annual net income/loss for 2023 was $0.275B, a 39.66% decline from 2022.
- Straumann Holding AG annual net income/loss for 2022 was $0.456B, a 4.29% increase from 2021.
Straumann Holding AG Annual Net Income/Loss
(Millions of US $) |
| 2024 |
$522 |
| 2023 |
$275 |
| 2022 |
$456 |
| 2021 |
$437 |
| 2020 |
$98 |
| 2019 |
$310 |
| 2018 |
$284 |
| 2017 |
$280 |
| 2016 |
$233 |
| 2015 |
$74 |
| 2014 |
$173 |
| 2013 |
$109 |
| 2012 |
$0 |
| 2011 |
$80 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$18.704B |
$2.845B |
|
The Straumann Group is a global leader in implant and restorative dentistry and oral tissue regeneration. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann currently employs approximately on thousand seven hundred ninety people worldwide and its products and services are available in more than sixty countries through its broad network of distribution subsidiaries and partners.
|
